Neovasc (NVCN) to Release Quarterly Earnings on Thursday

Neovasc (NASDAQ:NVCN) (TSE:NVC) is scheduled to announce its earnings results after the market closes on Thursday, March 21st. Analysts expect the company to announce earnings of ($0.13) per share for the quarter.

NASDAQ NVCN traded down $0.02 during trading hours on Thursday, reaching $0.45. 14,217 shares of the stock traded hands, compared to its average volume of 1,764,277. Neovasc has a 1 year low of $0.42 and a 1 year high of $15.50. The company has a market capitalization of $14.80 million, a price-to-earnings ratio of -0.01 and a beta of 1.62.

A number of equities research analysts have weighed in on the company. Zacks Investment Research downgraded Neovasc from a “buy” rating to a “hold” rating in a research report on Wednesday, January 16th. ValuEngine upgraded Neovasc from a “hold” rating to a “buy” rating in a research report on Friday, March 1st.

TRADEMARK VIOLATION WARNING: “Neovasc (NVCN) to Release Quarterly Earnings on Thursday” was posted by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at

Neovasc Company Profile

Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products.

Recommended Story: How to invest in blue-chip stocks

Earnings History for Neovasc (NASDAQ:NVCN)

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with's FREE daily email newsletter.

Leave a Reply